Financial statements Pharma Review
Balance sheet of Pharma Review
Company age:
Age:
11 y. 3 m. 6 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of PHARMA REVIEW
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 1 033 707,00 | 1 552 670,58 | 1 414 544,08 | 1 298 411,05 | 1 258 507,57 |
| A. Fixed assets | 4 574,66 | 15 623,66 | 8 035,11 | 813,49 | 2 647,12 |
| B. Current assets | 1 029 132,34 | 1 537 046,92 | 1 401 508,97 | 1 292 597,56 | 1 250 860,45 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 5 000,00 | 5 000,00 |
| D. Own shares (stocks) | - | 0,00 | 5 000,00 | 0,00 | - |
| Total liabilities | 1 033 707,00 | 1 552 670,58 | 1 414 544,08 | 1 298 411,05 | 1 258 507,57 |
| A. Equity | 850 663,79 | 1 436 925,83 | 1 231 873,93 | 1 217 441,46 | 1 042 774,38 |
| B. Liabilities and provisions for liabilities | 183 043,21 | 115 744,75 | 182 670,15 | 80 969,59 | 215 733,19 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.